Aortic valve calcification in systemic lupus erythematosus
Authors:
- 1 December 2006
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 15 (12) , 873-876
Abstract
Aortic valve calcification is associated with atherosclerosis in the general population. We investigated the prevalence of and associates of aortic valve calcification in systemic lupus erythematosus (SLE). One-hundred and ninety-nine SLE patients enrolled in a clinical trial had aortic valve calcification assessed by helical CT. The patients had a mean age of 44.3 = 11.4 years and were 92% female, 61% Caucasian, 34% African-American, 2% Asian and 2% Hispanic. Aortic valve calcification was present in 1.5%, whereas coronary calcium was found in 43% and carotid plaque in 17%. Among cardiovascular risk factors, hs-CRP (P = 0.0592), fibrinogen (P = 0.0507), and lipoprotein(a) (P = 0.0250), were associated with aortic valve calcification. Prednisone use (P = 0.049) and use of methotrexate (P = 0.0174) were also associated with aortic valve calcification. Aortic valve calcification was associated with antiphospholipid antibody positivity (0.0287) (lupus anticoagulant, by dilute Russell viper venom time). It was not associated with coronary calcium or carotid plaque. Aortic valve calcification, although rare in SLE, was associated with some novel cardiovascular risk factors and with a marker of hypercoagulability (lupus anticoagulant). In contrast to the general population, aortic valve calcification in SLE is not associated with subclinical measures of atherosclerosis, such as coronary calcium or carotid plaque.Keywords
This publication has 29 references indexed in Scilit:
- Heart valve calcification in young patients with systemic lupus erythematosus: A window to premature atherosclerotic vascular morbidity and a risk factor for all-cause mortalityAtherosclerosis, 2006
- Relation of aortic valve sclerosis to risk of coronary heart disease in African-AmericansThe American Journal of Cardiology, 2005
- Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosisEuropean Heart Journal, 2003
- Transesophageal and transthoracic echocardiography and Doppler-examinations in systemic lupus erythematosusScandinavian Journal of Rheumatology, 2001
- Predictors of Outcome in Severe, Asymptomatic Aortic StenosisNew England Journal of Medicine, 2000
- Clinical Factors Associated With Calcific Aortic Valve DiseaseJACC, 1997
- Changing Aspects of the Natural History of Valvular Aortic StenosisNew England Journal of Medicine, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Cardiovascular abnormalities in systemic lupus erythematosusJournal of Clinical Ultrasound, 1981